![](/_next/image?url=https%3A%2F%2Ffirebasestorage.googleapis.com%2Fv0%2Fb%2Fmantic-markets.appspot.com%2Fo%2Fdream%252FXHtFuYvub-.png%3Falt%3Dmedia%26token%3D54e4154f-0590-4d19-817c-59a609270118&w=3840&q=75)
Basic
30
Ṁ1.9k2028
75%
chance
1D
1W
1M
ALL
Will have to adjust resolve date based on when CDC releases the data. If the rate decreases while all the products are pulled from market, or not sold in a reasonable quantity, it won't count.
Get Ṁ600 play money
Sort by:
Related questions
Related questions
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by 01/01/2025?
14% chance
Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
70% chance
Reliable Reporting indicating that more than 3% of Americans are taking GLP-1 agonists in 2024
36% chance
Will US obesity be half or less of the current rate in 2050?
61% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
33% chance
Will the US obesity rate stop rising by 2024?
20% chance
More than 10% of US citizens will be on prescription drugs for weight loss by 2031
57% chance
Affordable weight loss drugs before 2030?
60% chance
Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
82% chance